BHV-1510

PBI-410 · Biohaven Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV-1510, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors [Phase 1, Phase 2]